✦ LIBER ✦

CE2 HEALTH ECONOMIC ASSESSMENT OF THE ATAC TRIAL COMPARING ANASTROZOLE VERSUS TAMOXIFEN IN ADJUVANT TREATMENT OF POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER

✍ Scribed by Annemans, L; Moeremans, K; Lamarque, H

Book ID: 123058440
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 60 KB
Volume: 6
Category: Article
ISSN: 1098-3015
DOI: 10.1016/S1098-3015(10)61604-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CN3 HEALTH ECONOMIC EVALUATION BASED ON

CN3 HEALTH ECONOMIC EVALUATION BASED ON THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL COMPARING ANASTROZOLE VERSUS TAMOXIFEN IN ADJUVANT TREATMENT OF POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER

✍ K Moeremans; L Annemans 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Cost-effectiveness of anastrozole compar

Cost-effectiveness of anastrozole compared to tamoxifen in hormone receptor–positive early breast cancer. Analysis based on the ATAC trial

✍ K. MOEREMANS; L. ANNEMANS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 150 KB

Evaluation of endometrial thickness in h

Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole

✍ Mario Valenzano Menada; Sergio Costantini; Melita Moioli; Stefano Bogliolo; Andr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 250 KB

Comparison of anastrozole versus tamoxif

Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer : The pre-operative “Arimidex” compared to Tamoxifen (PROACT) trial

✍ Luigi Cataliotti; Aman U. Buzdar; Shinzaburo Noguchi; Jose Bines; Yuichi Takatsu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract ## BACKGROUND The Pre‐Operative “Arimidex” Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a preoperative treatment of postmenopausal women with large, operable (T2/3, N0‐2, M0), or potentially operable (T4b, N0‐2, M0) br

Histopathological assessment of anastroz

Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial

✍ Masafumi Kurosumi; Yuichi Takatsuka; Toru Watanabe; Shigeru Imoto; Hideo Inaji; 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 357 KB